Skip to main content
Patent
Medicine
Pharma

Health Care at Reasonable Cost: The Goals of the Hatch-Waxman Act as Seen from 2024

This episode is audio from the Goals of the Hatch-Waxman Act as Seen from 2024 panel from the Engelberg Center’s Hatch-Waxman at 40 and Beyond Symposium. It was recorded on September 26, 2024.

Bob Armitage, Intellectual Property Consultant

Alfred B. Engelberg

Katherine Strandburg, Engelberg Center on Innovation Law & Policy, NYU School of Law (moderator)